Eudaimonia Partners’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-254
Closed -$31K 572
2021
Q1
$31K Buy
+254
New +$31K 0.01% 792